×

Neville Registrars is delighted to welcome Rockpool Acquisitions Plc as the newest addition to its list of client companies.

Rockpool Acquisitions is seeking to acquire a Northern Ireland based company seeking additional capital to help it grow.

Further information can be found on the Company's website: http://rockpoolacquisitions.plc.uk/

Close

×

RNS Number : 6510K

Crimson Tide PLC

11 July 2017

 

CRIMSON TIDE PLC

("Crimson Tide" or "the Company")

SIGNIFICANT MPRO5 SUBSCRIPTION CONTRACT WIN IN THE NETHERLANDS

 

Crimson Tide (TIDE), the AIM-quoted provider of mpro5 – Smart Mobile Working, has secured a long term contract in The Netherlands with one of the world's largest facilities management companies.

The contract is worth a minimum of €200,000 with the potential to rise to a maximum of over €1m and is for a 48 month period

The client will use mpro5 for mobile scheduling, reporting and auditing of workflow and activities. Users of mpro5's enterprise mobile solutions pay a monthly subscription for software, cloud infrastructure, installation and all services required by their out-of-office teams. This makes for easy initial adoption, often followed by wider internal take-up as the performance benefits are established.

Barrie Whipp, Executive Chairman, commented: "We have been making a number of strategic growth investments internationally and this contract represents an excellent foundation for our expansion in Northern Europe. mpro5 is well positioned for organisations that have larger geographic footprints which, with our Microsoft Azure Cloud infrastructure, we are able to support."

For further information about the Company, please see www.crimsontide.co.uk, for specific information about mpro5 please visit the new http://www.mpro5.com

 

Contacts:

Crimson Tide plc, Barrie Whipp – 01892 542 444

WH Ireland Limited, James Joyce / James Bavister – 020 7220 1666

 

Notes to editors Founded in 1996 and quoted on AIM since 2006, Crimson Tide plc is the provider of mpro5 – Smart Mobile Working. mpro5 is delivered on smartphones, tablets and PDAs, and enables companies to transform their businesses and strengthen their workforces. Crimson Tide offers a global service, working with some of the world's leading companies, tailoring mpro5 to suit customer needs. Developed over 10 years by its world-class team, mpro5 is the smart choice for organisations large and small that want to improve productivity and save money. mpro5 is a platform-agnostic mobility suite fully hosted on Microsoft Azure, so customers are quickly up and running and the service is scalable and robust. It is provided on subscription, so clients can immediately see a return on their investment. mpro5 not only helps people improve their day-to-day working methods while saving employers money, it also saves lives, by enabling haemophilia patients to verify the safety of their medication before use. mpro5 clients come from a diverse range of industries allowing the Company to listen, share and find the best solution for all mobility needs.

 

The information contained within this announcement is deemed by the Company to constitute inside information under the Market Abuse Regulation (EU) No. 596/2014.

This information is provided by RNS

The company news service from the London Stock Exchange

 

END

 

 

CNTDBLFFDDFLBBF

Close

×

RNS Number : 3498H

Midatech Pharma PLC

07 June 2017

 

 

 

 

7 June 2017

Midatech Pharma PLC

("Midatech", "Company" or "Group")

 

Midatech signs global license agreement to investigate panobinostat for treatment of brain cancers

 

Midatech Pharma (AIM: MTPH; Nasdaq: MTP), the international specialty pharmaceutical company focused on commercialising and developing products in oncology, today announces that it has signed a global licensing agreement with Novartis for the oncology compound panobinostat. Panobinostat will be developed by Midatech for the treatment of Diffuse Intrinsic Pontine Glioma (DIPG) as a continuation of its existing MTX110 program, and potentially for Glioblastoma (GBM).

 

In pre-clinical test models, panobinostat, which is a pan-HDAC inhibitor, demonstrated very high potency against DIPG tumour cell lines. In one such study panobinostat was the most effective of more than 80 anti-cancer agents tested.

 

Midatech's MTX110 program is focused on the treatment of DIPG, a childhood brain cancer that is nearly always fatal, with a median survival of approximately 9 months. Using a technique called Convection Enhanced Delivery, MTX110 is infused directly into the brain tumour, and diffuses through and around it. This technique allows for elevated drug concentrations to be delivered to the tumour, while at the same time minimizing systemic toxicity and peripheral side-effects. MTX110 has been used to treat 5 patients to date in the USA and UK under its compassionate use program. In these patients MTX110 has been well tolerated thus far. We believe it holds promise as a potential therapeutic treatment for DIPG, for which there are currently no approved or effective therapies. Clinical studies in patients are planned to commence during 2017. Financial terms have not been disclosed.

 

Jim Phillips, CEO of Midatech Pharma, said: "In line with our strategy to focus on oncology and expand our product mix, we are pleased that Novartis recognises our unique capability to use their product panobinostat alongside our technology to treat orphan cancers. We look forward to driving it through development for treatment of DIPG, and make a real difference to the children suffering from this devastating and terminal disease."

 

– Ends –

 

For more information, please contact:

 

Midatech Pharma PLC

Jim Phillips, CEO

Tel: +44 (0)1235 841575

www.midatechpharma.com

 

Panmure Gordon (UK) Limited (Nominated Adviser and Broker)

Corporate Finance

Freddy Crossley / Duncan Monteith

Broking

Tom Salvesen

Tel: +44 (0)20 7886 2500

 

Consilium Strategic Communications (Financial PR)

Mary Jane Elliott / Ivar Milligan / Cameron Standage

Tel: +44 (0)20 3709 5700

Email: midatech@consilium-comms.com

 

Westwicke Partners (US Investor Relations)

Chris Brinzey

Tel: +1 339 970 2843

Email: chris.brinzey@westwicke.com

 

Notes for Editors

 

About Midatech Pharma PLC

 

Midatech is an international specialty pharmaceutical company focused on oncology and other therapeutic areas with a US commercial operation marketing four cancer care supportive products, and co-promoting two others. Midatech's strategy is to internally develop oncology products and collaborate with partners in other therapy areas, and to drive growth both organically and through strategic acquisitions. The Company's R&D activities are supported by two breakthrough drug delivery technologies: Q-Sphera for sustained release and our proprietary gold nanoparticles. The Group, listed on AIM: MTPH and Nasdaq: MTP, employs c.110 staff in four countries. For further company information see: www.midatechpharma.com

This information is provided by RNS

The company news service from the London Stock Exchange

 

END

 

 

AGRZMGGVMVZGNZZ

Close

×

RNS Number : 0564H

Osirium Technologies PLC

05 June 2017

 

 

 

Press release                                                                                                                  5 June 2017

 

 

Osirium Technologies plc

 

("Osirium")

 

Osirium named a 'Cool Vendor' by Gartner

 

Osirium Technologies plc (AIM: OSI.L), a UK based cyber-security software provider, is pleased to announce that it has been included in the list of "Cool Vendors" in the "Cool Vendors in Identity and Fraud Management 2017' report by Gartner, Inc.

 

David Guyatt, Chief Executive Officer at Osirium Technologies commented:

"We believe being included in Gartner's Cool Vendor report is very significant for this business.  Also, we feel seeing Osirium's PAM platform evaluated in this report demonstrates the teams dedication and innovative approach in breaking through the cyber security newsflow with a really exciting niche.  For us, this is a company-wide achievement and we will certainly be enjoying the attention and benefits of becoming a Cool Vendor."

 

Osirium will again be a part of Infosecurity Europe 2017 at Olympia London from 6th to 8th June, the most important and largest Cyber Security event of the year exhibiting on stand F210.  Investors and analysts can attend for free by registering before the show (cost on the day) via Osirium's website, see link below.

https://osirium.com/infosec-2017

 

–      Ends  –

For further information:

 

Osirium Technologies plc	Tel: 44 (0) 118 324 2444
David Guyatt, Chief Executive Officer Rupert Hutton, Chief Financial Officer www.osirium.com
Panmure Gordon (UK) Limited (Nominated Adviser and Broker)	Tel: +44 (0) 20 7886 2500
Andrew Godber / Peter Steel  – Corporate Finance Charles Leigh-Pemberton – Corporate Broking
Yellow Jersey PR (Financial PR) Sarah Hollins	Tel: +44 (0) 7764 947137

 

 

 

 

 

 

Notes to Editors:

About Osirium

Osirium Technologies plc (AIM: OSI.L), is a UK based cyber-security software provider.  Osirium protects critical IT assets, infrastructures and devices by preventing targeted cyber-attacks from directly accessing Privileged Accounts, removing unnecessary access and powers of Privileged Account users, deterring legitimate Privileged Account users from abusing their roles and containing the effects of a breach if one does happen.

 

Osirium has defined and delivered what the Directors view as the next generation PAM (Privileged Access Management) solution.  The team has developed the concept of Virtual Air Gap to separate users from passwords, with Osirium's Privileged Task Management module further strengthening Privileged Account security and delivering impressive return on investment benefits for customers.

 

Founded in 2008 and with its headquarters in Reading, UK, the Group was admitted to AIM in April 2016.  For further information please visit www.osirium.com

 

This information is provided by RNS

The company news service from the London Stock Exchange

 

END

 

 

NRAFTMITMBMMBFR

Close

×

RNS Number : 5412G

Trakm8 Holdings PLC

31 May 2017

 

31 May 2017

TRAKM8 HOLDINGS PLC

 

("Trakm8" or the "Group")

 

Iceland Foods Awards Trakm8 Optimisation & Telematics Contract Extension

 

 

Trakm8, the AIM-listed telematics and data provider to the global market place, is pleased to announce it has been awarded a contract extension by Iceland Foods Limited, the UK's leading frozen food retailer.

 

The contract extension covers the provision of Trakm8's Route Monkey Optimisation software and updates Trakm8's Roadsense telematics with Trakm8's latest "RoadHawk 600" integrated 4G video and telematics solution, with data provided via Trakm8's latest data solution "Insight". The new contract extension will run until April 2024.

 

Trakm8, through Route Monkey and Roadsense, has been providing solutions for over 1,500 Home delivery vehicles and optimising over 11 million deliveries per year. The next generation solutions will provide even better optimisation of these deliveries, far better insights into how the vehicles are being driven and the vehicle service requirements. The solutions will be fully integrated within the Trakm8 software and Iceland's EPOS.

 

John Watkins, Executive Chairman of Trakm8 commented: 

"We have been working with Iceland Foods for over four years providing optimisation and telematics solutions. Iceland is a market leader in adopting new technology and we are delighted that it is the first significant customer for our next generation integrated products and solutions.

 

"It is validation of the acquisitions of both Route Monkey & Roadsense and Trakm8's product strategy to integrate Optimisation, Camera and Telematics technologies.

 

"This is a long term contract that provides predictable revenues for the years ahead."

 

-ends-

 

For further information please contact:

 

Trakm8 Holdings plc	+44 (0) 174 785 8444
John Watkins, Executive Chairman
James Hedges, Finance Director
finnCap (Nomad and broker)	+44 (0) 20 7220 0500
Ed Frisby / Simon Hicks – corporate finance
Tim Redfern / Richard Chambers – corporate broking
MHP Communications	+44 (0) 20 3128 8100
Reg Hoare / Charlie Barker

About Trakm8

Trakm8 is a UK based technology leader in fleet management, insurance telematics, optimisation and dashboard camera systems. Through IP owned technology, the Group analyses data collected by its installed base of telematics units to fine tune the algorithms that are used to produce its telematics based solutions; these score driver behaviour, monitor vehicle health and continuously improve the security and operational efficiency of both private drivers and company fleets.

 

The Group's product portfolio includes cameras (including the recently launched integrated telematics camera), self-installed telematics units and technology to eliminate distracted driving due to mobile phones, and it has over 191,000 installed units reporting to its servers. 

 

Headquartered in Dorset with a manufacturing facility in the West Midlands, the Group supplies, through its dedicated business units Fleet, Optimisation, Insurance and Automotive, many well-known customers in the UK and internationally including the AA, Saint Gobain, EON, Direct Line Group and Young Marmalade.

 

Trakm8 has been listed on the AIM market of the London Stock Exchange since 2005.

 

www.trakm8.com / @Trakm8

 

 

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

 

This information is provided by RNS

The company news service from the London Stock Exchange

 

END

 

 

CNTFMGFKLGNGNZG

Close

×

RNS Number : 4310G

Crimson Tide PLC

30 May 2017

 

Crimson Tide PLC

("Crimson Tide" or the "Company")

International Expansion Update

Crimson Tide (TIDE), the AIM‐quoted provider of mpro5 ‐ Smart Mobility as a Service, is pleased to update the market on progress with its international expansion strategy, which it has previously indicated will drive further growth opportunities. Strategic partnerships with tactical investments are being made in new geographies, complementing the organic growth being delivered in the UK.

Particular areas of progress are as follows:

 

 

·     Ireland – first phase contract secured with one of the largest state-sponsored companies in Ireland. The initial agreement is for approximately 200 subscribers who will be using mpro5 for remote working. This transaction has been closed with the Company's partner, Vodafone. To support the ongoing growth in Ireland, Wesley Dunn has been promoted to a full time role in Business Support.

 

·     United States –  Dagen Wilhelm has been appointed as International Healthcare Consultant. Ms. Wilhelm, based in the Washington D.C. area, will focus on business development for mpro5 with specific emphasis on the Company's healthcare offering. Dagen will be the key contact for our participation in the CARIN Allliance, which focuses on delivering solid pharmacovigilance and digitalised healthcare. The CARIN Alliance is a bipartisan, multi-sector collaborative, working to advance consumer-directed exchange of health information.  Further to this, Crimson Tide is also in the process of establishing membership of RX360 – an international Pharmaceutical Supply chain consortium.

 

·     Netherlands – Following the recruitment of Erik-Jan Smulder, a seasoned sales professional previously with BlackBerry, the Company has signed an important pilot project with one of the world's leading Facilities Management companies, based in The Netherlands, which is looking to combine mpro5's smart mobility with Internet of Things ("IoT") enabled functionality. The pilot has commenced and the Company is hopeful that this will lead to a long term commercial agreement in the near future.

 

·     Denmark – The Company has secured its first contract with a Scandanavian company with a global footprint involved in the food processing industry. The use of mpro5 will enable staff to check workflows as components move through the supply chain. The initial deployment is small but expected to increase as the benefits of mpro5 are recognised.

 

·     UAE – our agreement with the British Centres for Business, ("BCB") has started to produce Enterprise level opportunities to the extent that we are pleased to announce the appointment of Senior Consultant Brad Manser with immediate effect. Mr. Manser, who is based in Dubai, will act as Director of Business Development for the Middle Eastern region. Brad has a wealth of experience in the area with previous roles as Operations Manager, Chief Operating Officer and Managing Director for a number of companies within the region.

 

·     Australia. The Company has got off to a good start with its new partner, Mobilise IT , based in Melbourne and will be visiting the region shortly to progress emerging opportunities. 

 

The Company is also pleased to announce the appointment of Barry Finnegan, an IoT strategist who will help develop our nascent investment in IoT technologies on mpro5. IoT has considerable benefits for intelligent and proactive data collection, particularly regarding smart sensors from motion to temperature & humidity, and Bluetooth devices which, we believe, represents a significant opportunity for mpro5 and Crimson Tide.

Barrie Whipp, Executive Chairman of Crimson Tide, said: "We are delighted with the progress that we have made with our international sales effort in such a short space of time and which underpins our belief that mpro5 has wide reaching appeal on a global basis. This is just the start of our international journey and I am confident that we will experience many more successes and wide scale adoption in these and other geographies as our reputation continues to grow."

For further information please contact:

 

Crimson Tide plc Barrie Whipp / Steve Goodwin	01892 542 444
WH Ireland James Joyce / James Bavister	020 7220 1666
Alma PR Josh Royston / Robyn Fisher	O77 8090 1979 / 075 4070 6191

 

Notes to editors

1. Founded in 1996 and quoted on AIM since 2006, Crimson Tide plc is the provider of mpro5 ‐ Smart Mobility as a Service (SMaaS). mpro5 is delivered on smartphones, tablets and PDAs, and enables companies to transform their businesses and strengthen their workforces.

2. Crimson Tide offers a global service, working with some of the world's leading companies, tailoring mpro5 to suit customer needs. Developed over 10 years by its world‐class team, mpro5 is the smart choice for organisations large and small that want to improve productivity and save money.

3. mpro5 is a platform‐agnostic mobility suite fully hosted on Microsoft Azure, so customers are quickly up and running and the service is scalable and robust. It is provided on subscription, so clients can immediately see a return on their investment.

4. mpro5 not only helps people improve their day‐to‐day working methods while saving employers money, it also saves lives, by enabling haemophilia patients to verify the safety of their medication before use. mpro5 clients come from a diverse range of industries allowing the Company to listen, share and find the best solution for all mobility needs.

 

This information is provided by RNS

The company news service from the London Stock Exchange

 

END

 

 

MSCBUGDULBDBGRL

Close

×

Neville Registrars is delighted to welcome Solid State PLC as the newest addtion to its list of client companies.

Solid State PLC is a high value-add manufacturer and specialist design-in distributor to the electronics industry. It has particular expertise in computing technologies, electronic components, secure communications and batteries. Typical clients operate in aerospace, environmental, government, oil & gas and transportation markets.

Further information can be found on the Company's website: https://www.solidstateplc.com/

Close

×

RNS Number : 1728G

World Trade Systems PLC

24 May 2017

 

World Trade Systems PLC

17 May 2017

 

WORLD TRADE SYSTEMS PLC ("WTS") 

 

17th May 2017

 

WTS plc announces that it has entered into a memorandum of understanding ("MOU") in connection with a commercial cooperation agreement with a well-established international company that aligns with the overarching goals and vision of WTS plc.  The Board of WTS believes that this will result in the expansion of the business of WTS China by diversifying its product range and extending its market reach. R&D and market distribution co-operation with Biestmilch GmbH ("Biestmilch")

WTS plc has entered into an MOU with 'Biestmilch' which was founded in 1999 by Dr Susann Kraftner , based in Lindau, Germany. 

Dr Susann Kraftner and Dr Arne Schumacher are the current Managing Directors. Dr Kraftner has over 19 years' experience in the development of Biestmilch products. She is also an author and medical doctor with experience of working in pharmaceutical organisations.

Beistmilch has already developed promising high end products for immune system performance and anti-depression chewable tablets with excellent results. Biestmilch has established their tested and effective products including the chewable tablets, to assist with immunity and the conditions of stress. Beistmilch's booster tablets have been described as "kicks in stronger than coffee while boosting your immunity at the same time". Biestmilch's object is to create a market leading brand of biological body immunity boost food.

WTS plc believes that through close collaboration with Biestmilch we can pool market knowledge and R&D resources to help both companies achieve synergistic benefits by distributing new healthcare and cell based products in an international market.

 

 WTS plc will seek any necessary authorities in due course.

 

For more information, please contact the following:

World Trade Systems plc

Mr. Shao Chen, Vice Chairman, shaochen@wtscn.com

Mr. AKM Ismail, Executive Director, akm.ismail@gmail.com

 

Information on WTS plc

WTS plc is a health food products company that develops, manufactures and distributes health food products targeted at mid/high end consumers. Having previously had no business activities for a number of years, the Company began its current business activities in July of 2016 and is in the process of applying for a re-listing of its shares on the Standard Segment of the Official List of the Financial Conduct Authority.

Information on WTS China

Based on its expertise in the Chinese health food industry, with a focused product strategy, a progressive marketing plan, and in depth understanding of consumer trends, WTS China aims to become a comprehensive health food solution provider. WTS China is located in Suzhou, Jiangsu Province, in the central part of eastern China.

WTS China's current health drinks use collagen and other natural ingredients aimed at providing consumers with healthy food supplements containing nutrients which aim to support the body's immune system, improve digestion, lower cholesterol and blood pressure and promote healthier organ functions, smoother and more elastic skin and better complexion. WTS China is active in R&D developing additional products.

WTS China's  vision is to become a leading player in distributing many high quality health food products throughout China.

 

This information is provided by RNS

The company news service from the London Stock Exchange

 

END

 

 

STREAESLAEDXEAF

Close

×

RNS Number : 0136G

Trakm8 Holdings PLC

24 May 2017

 

24 May 2017

TRAKM8 HOLDINGS PLC

 

("Trakm8" or the "Group")

 

Roadside Assistance Technology Company Awards Trakm8 Telematics Contract

 

 

Trakm8, the AIM-listed telematics and data provider, is pleased to announce it has been awarded an initial contract by a roadside assistance technology company, to supply devices and data.

 

The initial contract includes a number of devices for the initial launch, along with integration engineering fees.

 

The contract is for launch in July 2017 to the customer's roadside assistance partners in Europe.  The initial focus will be in the UK and Holland. It is expected that the solution will be extended to other European markets in due course.

 

Trakm8 will provide its latest generation Connect 300 plug in telematics device. Data supplied will be from the Trakm8connectedcare solution to monitor the vehicle health and usage based on Trakm8's extensive automotive diagnostic knowledge.

 

 

John Watkins, Executive Chairman of Trakm8 commented: 

"We are delighted to win another customer for Trakm8's automotive telematics solutions. We have been providing telematics on extended trial with our Trakm8connectedcare product for about 12 months. It is also encouraging that this solution is expected to be offered in multiple countries.

 

"This contract is expected to be a significant one and provides additional visibility for our expectations for this financial year and beyond."

 

 

-ends-

 

For further information please contact:

 

Trakm8 Holdings plc	+44 (0) 174 785 8444
John Watkins, Executive Chairman
James Hedges, Finance Director
finnCap (Nomad and broker)	+44 (0) 20 7220 0500
Ed Frisby / Simon Hicks – corporate finance
Tim Redfern / Richard Chambers – corporate broking
MHP Communications	+44 (0) 20 3128 8100
Reg Hoare
Charlie Barker

 

About Trakm8

Trakm8 is a UK based technology leader in fleet management, insurance telematics, optimisation and dashboard camera systems. Through IP owned technology, the Group analyses data collected by its installed base of telematics units to fine tune the algorithms that are used to produce its telematics based solutions; these score driver behaviour, monitor vehicle health and continuously improve the security and operational efficiency of both private drivers and company fleets.

 

The Group's product portfolio includes cameras (including the recently launched integrated telematics camera), self-installed telematics units and technology to eliminate distracted driving due to mobile phones, and it has over 191,000 installed units reporting to its servers. 

 

Headquartered in Dorset with a manufacturing facility in the West Midlands, the Group supplies, through its dedicated business units Fleet, Optimisation, Insurance and Automotive, many well-known customers in the UK and internationally including the AA, Saint Gobain, EON, Direct Line Group and Young Marmalade.

 

Trakm8 has been listed on the AIM market of the London Stock Exchange since 2005.

 

www.trakm8.com / @Trakm8

 

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

This information is provided by RNS

The company news service from the London Stock Exchange

 

END

 

 

CNTUOSSRBSAVUAR

Close

×

RNS Number : 0154G

SpaceandPeople PLC

24 May 2017

 

24 May 2017

SpaceandPeople plc

Prestigious Property Win

SpaceandPeople has signed an exclusive contract with British Land for experiential marketing and outdoor opportunities in their London portfolio of venues

SpaceandPeople (AIM: SAL), the retail, promotional and brand experience specialist, is pleased to announce it has commenced an exclusive multi-year contract to manage the promotional space across British Land's portfolio of outdoor public spaces in London.

Having entered an exclusive contract with British Land during 2015 to manage the promotional space across their shopping centre and outdoor shopping park portfolios, they have now extended this agreement to include their London outdoor venues.

These venues include the prestigious Broadgate, Paddington Central and Regent's Place.

Matthew Bending, SpaceandPeople CEO, said:

"This is a significant endorsement of SpaceandPeople, with a major client choosing to extend their relationship with us to include a number of the most prominent public spaces in London."            

Contact details: 

SpaceandPeople Plc	0845 241 8215
Matthew Bending, Gregor Dunlay
Cantor Fitzgerald Europe	020 7894 7000
David Foreman, Will Goode (Corporate Finance)
Alex Pollen (Sales)

 

About SpaceandPeople

SpaceandPeople facilitates and manages promotional space for marketing campaigns and retailing in shopping centres, railway stations, retail parks, airports and other high footfall locations. SpaceandPeople is at the forefront of developing the concept of space as an advertising and promotional medium. It offers consumer brands the opportunity to promote their products through direct engagement with consumers through a mix of experiential marketing events and complementary above the line advertising and multimedia campaigns. SpaceandPeople offers a comprehensive service covering brokerage, consultancy and venue centric media buying. SpaceandPeople is independently funded and its shares are admitted to trading on AIM. The Company operates in the UK and Germany and also in India.

 

This information is provided by RNS

The company news service from the London Stock Exchange

 

END

 

 

NRAOKNDKPBKDQPB

Close